Torcetrapib and Atorvastatin -- Should Marketing Drive the Research Agenda?

Creator

Avorn, Jerry

Bibliographic Citation

New England Journal of Medicine 2005 June 23; 352(25): 2573- 2576

Permanent Link

Find in a Library
Full Text from Publisher
http://hdl.handle.net/10822/980789

Date

2005-06-23

Subject

Marketing; Research; Drugs and Drug Industry; Human Experimentation Policy Guidelines / Institutional Review Boards; Social Control of Human Experimentation; Business Ethics; Scientific Research Ethics;

Collections

EthxWeb: Literature in Bioethics

Metadata

Show full item record